back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-05-05 11:50 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+7,645 vol |
7,645 | |
| Filed 2021-04-30 13:54 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$344,906
+11,037 vol $31.25 each |
11,037 | |
| Filed 2021-04-30 13:53 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,037 vol |
0 | |
| Filed 2020-10-26 13:51 Tx date 2020-10-21 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-10,009 vol |
0 | |
| Filed 2020-05-04 12:07 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
11,037 | |
| Filed 2020-05-04 12:05 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$181,262
+10,009 vol $18.11 each |
10,009 | |
| Filed 2020-05-04 12:03 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,633 vol |
0 | |
| Filed 2019-05-10 17:10 Tx date 2019-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-9,885 vol |
0 | |
| Filed 2019-05-06 15:48 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+10,633 vol |
10,633 | |
| Filed 2019-05-06 15:46 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$233,582
+9,885 vol $23.63 each |
9,885 | |
| Filed 2019-05-06 15:43 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,881 vol |
0 | |
| Filed 2019-05-06 15:41 Tx date 2017-09-21 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-12,803 vol |
0 | |
| Filed 2018-05-28 Tx date 2018-05-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-21,612 vol |
12,803 | |
| Filed 2018-05-09 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+13,881 vol |
13,881 | |
| Filed 2018-05-09 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
||
| Filed 2018-05-07 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
||
| Filed 2018-05-07 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
||
| Filed 2018-05-07 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
14,285 | |
| Filed 2018-05-04 Tx date 2018-05-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$390,528
+21,612 vol $18.07 each |
34,415 | |
| Filed 2018-05-04 Tx date 2018-05-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-25,406 vol |
0 |